TSXV:NSP.H - Post by User
Comment by
Qwerty123456on Oct 08, 2020 1:48pm
128 Views
Post# 31689677
RE:NSP news - New Website & Provides Strategic Update
RE:NSP news - New Website & Provides Strategic UpdateGood day, has anyone heard specifics on the status of the Cavaltinib phase 2 trials as referenced in the last NR? Thanks.
"Through the Plasm Pharmaceutical joint venture with Biologic Pharmamedical, the Company continues to pursue a phase 2 clinical trial for a potential COVID-19 treatment utilizing the target drug CavaltinibTM, a curcumin extract derived from a Biologic patented technology."